iBio (IBIO) Inventory (2021 - 2022)
iBio (IBIO) posted quarterly Inventory of $3.9 million for Q2 2022, up 14344.44% year-over-year from N/an in Q2 2021, and up 18.79% quarter-over-quarter from $3.3 million in Q1 2022.
iBio (IBIO) Inventory (2021 - 2022) Analysis & Trends
iBio (IBIO) has reported Inventory for 2 consecutive years, with $3.9 million the latest figure, recorded in Q2 2022.
- In Q2 2022, Inventory rose 14344.44% year-over-year to $3.9 million; the TTM figure through Jun 2022 stood at $3.9 million (up 14344.44% YoY), while the FY2022 annual figure was $3.9 million, up 14344.44% from the prior year.
- Inventory improved to $3.9 million in Q2 2022 per IBIO's latest filing, from $3.3 million in the prior quarter.
- Across five years, Inventory topped out at $3.9 million in Q2 2022 and bottomed at $27000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | iBio | 175.21 Mn | 175.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 3.90 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 587,000.00 |
| Jun 30, 2021 | 27,000.00 |